Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment
NCT: NCT07752316 · COMPLETED
Brief Summary
Mild cognitive impairment (MCI) is a decline in memory and thinking that exceeds normal aging but does not substantially disrupt daily life, and it raises the risk of developing dementia. Effective treatments for its cognitive difficulties are few. This study tests whether transcranial alternating current stimulation (tACS), a non-invasive method that delivers a weak oscillating electrical current through scalp electrodes, can improve thinking and memory in older women with MCI. The current oscillates at 80 Hz, a frequency in the gamma range, because gamma brain rhythms support memory and attention and are disrupted in MCI. Thirty older women with MCI are randomly assigned to receive either active 80 Hz tACS or sham (placebo) stimulation. Participants and the person delivering the stimulation do not know the group assignment. Both groups complete the same cognitive tests before and after the sessions, measuring overall cognitive status, planning, visuospatial working memory, and reaction speed. The aim is to determine whether active 80 Hz tACS improves cognitive performance more than sham stimulation.
Frequently Asked Questions
What is Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment?
Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment is a clinical trial registered under NCT07752316. Current status: COMPLETED.
What is the status of NCT07752316?
The current status of NCT07752316 (Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment) is: COMPLETED.
When did Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment start?
Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment started on 2024-03-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.